Plasmid Manufacturing For Gene Therapies: An Outsourcing Partnership

With an increased demand for plasmids for targeted gene therapeutic delivery, partnering with a CDMO equipped with the capacity, expertise and equipment for plasmid DNA production is critical to ensuring a stable therapeutic supply.

Ajinomoto Bio-Pharma Services, an industry leader in microbial fermentation, discusses why optimizing, scaling-up and manufacturing plasmids are necessary for clinical to commercial program success and how their proven expertise and capabilities in cGMP production of biotherapeutics enable a strong, client-focused partnership, ensuring market success.